Read more at csl.com/we‑are‑csl/corporate‑governance/ code‑of‑responsible‑business‑practice CSL operates with a long‑term mindset. Over time, we have served patients with life-saving therapies and effective vaccines. We have achieved consistent top-line growth and strong margins, which helps fuel further growth by allowing us to re-invest in our own businesses. CSL is committed to the 2030 Strategy which includes Focus in core therapeutic areas, Innovation, Efficiency & Reliable Supply, Sustainable Growth, and Digital Transformation, with CSL people and our patients at the centre. We believe this is the best path, given our capabilities in an increasingly challenging and competitive world. The core elements of the 2030 Strategy are shown to the right. CSL’s 2030 Strategy CODE OF RESPONSIBLE BUSINESS PRACTICE CSL People & Culture Patients & Public Health INNOVATION EFFICIENCY & RELIABLE SUPPLY SUSTAINABLE GROWTH DIGITAL TRANSFORMATION FOCUS VALUES 8 Limited Annual Report 2023/24
RkJQdWJsaXNoZXIy MjE2NDg3